Overview
Portfolio
More
Ilium Partners
Paris, France
Advises tech companies on strategic and financial decisions and invests directly or via funds in tech companies across Western Europe and the US.
Portfolio
5+
Employees
3+
Founded
2019
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
EuropeUnited States
Sources
Ilium Partners
Advises tech companies on strategic and financial decisions and invests directly or via funds in tech companies across Western Europe and the US.
Portfolio
5+
Employees
3+
Founded
2019
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
EuropeUnited States
Sources
Showing 5 of 5 matched portfolio companies
Inderbitzin Solutions offers HealthML, a cloud-based platform that ingests, cleanses, and organizes disparate healthcare and life sciences data sources while ensuring secure integration with existing applications. This technology addresses the challenges of data sprawl and inefficient application interactions, enabling businesses to enhance their operational responsiveness and value without disrupting daily workflows.
M1 offers a unified platform that combines self‑directed brokerage accounts, high‑yield cash accounts, personal loans, and a spend card into a single interface. Users can trade stocks, ETFs and fractional shares commission‑free, earn interest on cash balances, borrow directly in the app, and trade cryptocurrency via a 1% fee, all with integrated dashboards and transparent fee disclosures.
Funding: $150.0M
Rough estimate of the amount of funding raised
Funding: $150.0M
Rough estimate of the amount of funding raised
Pact is a decentralized finance platform that utilizes automated market maker (AMM) technology to provide deep liquidity and low transaction fees for users. By leveraging blockchain infrastructure, Pact enables secure and transparent transactions, addressing the high costs and inefficiencies commonly associated with traditional financial systems.
Founded 202150+
Funding: $2.1M
Rough estimate of the amount of funding raised
Funding: $2.1M
Rough estimate of the amount of funding raised
Pathos develops an AI-enabled drug discovery platform that utilizes real-world oncology data and patient-derived functional genomic data to enhance patient selection and biomarker development. The platform aims to expedite the drug development process for biopharmaceutical companies by identifying promising therapeutic candidates that address significant unmet medical needs.
Funding: $365.0M
Rough estimate of the amount of funding raised
Funding: $365.0M
Rough estimate of the amount of funding raised
Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.
Funding: $7.0M
Rough estimate of the amount of funding raised
Funding: $7.0M
Rough estimate of the amount of funding raised